Reliability and initial validation of the ulcerative colitis endoscopic index of severity. - Wikidata - wikimedia - TriplyDB

Reliability and initial validation of the ulcerative colitis endoscopic index of severity.

Reliability and initial validation of the ulcerative colitis endoscopic index of severity.

http://www.wikidata.org/entity/Q34870256

about

Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data.Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis Review article: acute severe ulcerative colitis - evidence-based consensus statements.A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research.The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].Recent trends in diagnostic techniques for inflammatory bowel disease Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul.The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score Evaluation of the severity of ulcerative colitis using endoscopic dual red imaging targeting deep vessels.European evidence based consensus for endoscopy in inflammatory bowel disease.The role of mucosal healing in the treatment of patients with inflammatory bowel disease Endoscopic scoring systems for inflammatory bowel disease: pros and cons.Colonoscopic evaluation in ulcerative colitis."Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion.A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings.The role of capsule endoscopy in assessing mucosal inflammation in ulcerative colitis.Predicting outcomes in acute severe ulcerative colitis.Conventional drug therapy for inflammatory bowel disease.Ulcerative Colitis: What is the Optimal Treatment Goal and How Do We Achieve It?C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.Improving the utility of colonoscopy: Recent advances in practice.A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis.Elaboration and validation of Crohn's disease anoperineal lesions consensual definitions.Endoscopic Disease Activity in Inflammatory Bowel Disease.Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.Prediction of clinical and endoscopic responses to anti-tumor necrosis factor-α antibodies in ulcerative colitis.Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.A comparison of approaches for adjudicating outcomes in clinical trials.Polyp morphology: an interobserver evaluation for the Paris classification among international experts.Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study.Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.

P2860

Q28072104-FEBEE684-F40B-4321-B3C4-E3E505271F81 Q31140142-924FB7DC-0199-43A6-AECE-A46D57C61290 Q33607108-4EBD152E-A76D-45BF-8740-98333EBB89E9 Q33696416-98452FA5-D532-42DB-8D15-1A9DF52352F1 Q34528270-BA5D45C0-8B20-4072-AF13-E2AAD0E9A5D7 Q35169255-545691A7-5DA0-450F-AC0B-C603A61FD453 Q35625694-1C06ECC8-0309-4318-8BA0-26E74C5CF610 Q35626222-F3255EE4-F39C-4BA5-9775-41EF5C4AFF60 Q37095800-68C79B57-FFBF-4288-BB94-A0245753A70D Q37118462-370FF04D-0168-4603-919E-926924458AD5 Q37616248-CEA71C03-3308-4302-9DBA-8B41C5C0A256 Q38159096-23F406AA-B8DB-4B8C-A66D-F8B8E16309C6 Q38176299-6E543746-9294-43B3-82EE-3E9AF68535D2 Q38197726-3A113003-C414-4208-9F8D-D5C602B7006A Q38216220-8F454A6B-BD73-4533-A1E7-614AE9311EF1 Q38217234-E6DBCE0B-ED64-49A1-A6ED-E0FD96A486CB Q38219796-0E1CB0C7-DC36-4163-901C-96C25EED8858 Q38223324-4574C789-54AA-4C0F-AD23-6997C6890C02 Q38286166-7E184DCD-C964-4452-AD03-69A92064374C Q38293796-C3B8FEE3-7477-4A4A-87A8-6B74B9488D9D Q38331566-B4E69417-B8CD-4361-A963-3AA63B680BD6 Q38474301-F4D842B4-7C75-4410-98E6-FABF3ACA0E4E Q38531008-D0288C1C-0BD2-490B-B253-935C896783DB Q38554542-ED773481-7A18-494C-A605-88F407323618 Q38589686-4C94B675-1620-4E53-B0C3-AB8FE576F3E4 Q38609300-A33D7F53-7D60-401B-AF84-0BC1F94270B7 Q38664077-180E3415-2FDA-4F5A-AB20-65C76D04AAD1 Q38694153-02388576-8D0C-460D-9ECE-1695B914FE76 Q38768496-AFF4ACE2-5588-44C9-BE7A-5E4C28F590B7 Q38775457-3C86CDB8-64B7-40F7-A722-01326264F84C Q38797791-C53EDA25-BCD4-4DAF-BD85-8C8862821682 Q38906748-4CE4FCD7-4766-4412-8394-FAC6BB05B78C Q39064412-54AF882D-FC84-41C2-ACEC-780059506404 Q39098635-5EBC9A32-6177-40F6-A10E-1685A4809396 Q39360120-84A8A713-B9CD-4BCC-8A50-09EAD3C39F56 Q40230218-D9D5436B-3023-4985-8067-B49DF77BFAB4 Q40811180-A9284E07-D019-433B-8288-71AB009E7968 Q40926333-EF9ACA32-5533-4596-95CC-FD7FC47CB70A Q42280471-CECD676D-B854-4467-894F-D6EA413CEFB6 Q42375565-A017F9C9-EA78-4C66-AD3D-AAC54BB9CED2

P2860

Reliability and initial validation of the ulcerative colitis endoscopic index of severity.

http://www.wikidata.org/entity/Q34870256

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Reliability and initial valida ...... endoscopic index of severity.

@ast

Reliability and initial valida ...... endoscopic index of severity.

@en

Reliability and initial valida ...... endoscopic index of severity.

@nl

type

label

Reliability and initial valida ...... endoscopic index of severity.

@ast

Reliability and initial valida ...... endoscopic index of severity.

@en

Reliability and initial valida ...... endoscopic index of severity.

@nl

prefLabel

Reliability and initial valida ...... endoscopic index of severity.

@ast

Reliability and initial valida ...... endoscopic index of severity.

@en

Reliability and initial valida ...... endoscopic index of severity.

@nl

P1433

Q34870256-B94A8E19-03EB-4D96-B9F5-2D7E98A5EB1F

P1476

Q34870256-478558EC-97AA-4F8D-B26F-BCF9848E3623

P2093

Q34870256-022FC0FC-3F38-4EEC-AE8F-5AD520D06D7E

Q34870256-201EAD27-F4DF-4094-BDB0-6C6E73B349EA

Q34870256-22D1D6D2-3590-4652-B4D1-2372580607AC

Q34870256-45001A2C-46C9-4942-BC8F-B323306AE48B

Q34870256-458A023D-F63A-4E53-BB95-460DD99461E6

Q34870256-47410F1C-A7AF-4454-8BEF-DAEC081DEA27

Q34870256-8082907F-E824-437B-B79A-8BB810BA49F8

Q34870256-AA6D5647-2903-4177-BAE1-DE30A0987863

Q34870256-C38499B9-6B14-4DDA-BE56-CC11D9FFD95D

Q34870256-C4804E72-2FFC-45E2-85CC-DF3A88729CC5

P304

Q34870256-3E0BB40E-B1E0-47B6-9DD4-DADA2621D431

P31

Q34870256-CD1CF043-A26E-45A6-A26D-5C1B799E6AE1

P356

Q34870256-897B9D4C-C484-4731-BFC2-57BF1C9EC92B

P407

Q34870256-2BFC975C-0115-47A0-97BE-FB6C0511A019

P433

Q34870256-0DE1325B-209C-4507-A794-21CBB5D9B92D

P478

Q34870256-F6752AAF-7B66-4F5C-B896-3B269B89E80A

P50

Q34870256-05BDA96D-F765-43BA-A0B7-6678EF85DE4C

Q34870256-57A078AB-61E8-455B-9D2C-072D471E30F6

Q34870256-647EA875-EB29-4999-A590-F34B11CDD01C

P577

Q34870256-2214C370-7285-4748-9B8D-D187C62BD79F

P5875

Q34870256-E65A47A6-626B-40DB-A800-84023BA2269E

P698

Q34870256-9BAFF83A-8212-4DB2-BE12-98E7CBB0AD49

P356

J.GASTRO.2013.07.024

P1433

Gastroenterology

P1476

Reliability and initial valida ...... endoscopic index of severity.

@en

P2093

Bruce E Sands

http://www.w3.org/2001/XMLSchema#string

Bruce R Yacyshyn

http://www.w3.org/2001/XMLSchema#string

Christian A Bernhardt

http://www.w3.org/2001/XMLSchema#string

Dan Schnell

http://www.w3.org/2001/XMLSchema#string

Gary R Lichtenstein

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Mary

http://www.w3.org/2001/XMLSchema#string

Maria T Abreu

http://www.w3.org/2001/XMLSchema#string

Patrick Schnell

http://www.w3.org/2001/XMLSchema#string

Philippe R Marteau

http://www.w3.org/2001/XMLSchema#string

Piotr Krzeski

http://www.w3.org/2001/XMLSchema#string

P304

987-995

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2013.07.024

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Frédéric Colombel

Douglas G. Altman

Brian G. Feagan

P577

2013-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253334206

http://www.w3.org/2001/XMLSchema#string

P698

23891974

http://www.w3.org/2001/XMLSchema#string